presented by Julie Barkmeier-Kraemer PhD
Financial — Julie Kramer receives compensation from MedBridge for the production of this course. There are no other relevant financial relationships. Julie Barkmeier-Kraemer is a Professor at the University of Utah in the Division of Otolaryngology and she is Clinic Director for the Voice Disorders Center in the University of Utah Healthcare System. Non-financial — Julie Kramer is part of the working Group responsible for generating the Instrumental Voice Assessment Protocol supported by the ASHA. Julie Kramer’s research is focused on developing diagnostic methods, tools and treatment approaches for those with vocal tremor.
Satisfactory completion requirements: All disciplines must complete learning assessments to be awarded credit, no minimum score required unless otherwise specified within the course.
Julie Barkmeier-Kraemer PhD, CCC-SLP
Julie Barkmeier-Kraemer, PhD, CCC-SLP is a speech-language pathologist and professor in the Division of Otolaryngology, Clinic Director for the Voice Disorders Center, and Adjunct Faculty to the Communication Sciences and Disorders program at the University of Utah. Dr. Barkmeier-Kraemer received her M.A. and Ph.D. degrees from the Department of Speech Pathology and Audiology at the…Read full bio
1. Introduction to Speech Treatment for Vocal Tremor
The purpose of this chapter will be to summarize the key components of the voice evaluation with vocal tremor that are important in determining candidacy and optimal methods for treatment planning the includes speech treatment.
2. Principles of Speech Treatment for Vocal Tremor
The purpose of this chapter will be to highlight the key strategies for reducing the perception of vocal tremor during speech treatment.
3. Voice Evaluation with Vocal Tremor
The purpose of this chapter will be to highlight the key strategies for reducing the perception of vocal tremor during speech treatment case demonstrations. Participants will identify and describe the key principles regarding vocal tremor, identify and describe therapeutic methods used to achieve speech treatment objectives, and compare and contrast approaches used with individuals that have co-occurring spasmodic dysphonia.